» Articles » PMID: 28116311

Genetic and Epigenetic Regulation of Aortic Aneurysms

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2017 Jan 25
PMID 28116311
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Aneurysms are characterized by structural deterioration of the vascular wall leading to progressive dilatation and, potentially, rupture of the aorta. While aortic aneurysms often remain clinically silent, the morbidity and mortality associated with aneurysm expansion and rupture are considerable. Over 13,000 deaths annually in the United States are attributable to aortic aneurysm rupture with less than 1 in 3 persons with aortic aneurysm rupture surviving to surgical intervention. Environmental and epidemiologic risk factors including smoking, male gender, hypertension, older age, dyslipidemia, atherosclerosis, and family history are highly associated with abdominal aortic aneurysms, while heritable genetic mutations are commonly associated with aneurysms of the thoracic aorta. Similar to other forms of cardiovascular disease, family history, genetic variation, and heritable mutations modify the risk of aortic aneurysm formation and provide mechanistic insight into the pathogenesis of human aortic aneurysms. This review will examine the relationship between heritable genetic and epigenetic influences on thoracic and abdominal aortic aneurysm formation and rupture.

Citing Articles

SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression.

Leng S, Li H, Zhang P, Dang Z, Shao B, Xue S Arterioscler Thromb Vasc Biol. 2024; 45(2):238-259.

PMID: 39633576 PMC: 11748913. DOI: 10.1161/ATVBAHA.124.321421.


S-adenosyl-L-methionine supplementation alleviates aortic dissection by decreasing inflammatory infiltration.

Wang Q, An J, Zhou W, Zhang Y, Huang J, Liao G Nutr Metab (Lond). 2024; 21(1):67.

PMID: 39160585 PMC: 11331618. DOI: 10.1186/s12986-024-00837-5.


Smooth muscle cell phenotypic switching occurs independent of aortic dilation in bicuspid aortic valve-associated ascending aortas.

Balint B, Bernstorff I, Schwab T, Schafers H PLoS One. 2024; 19(7):e0306515.

PMID: 38954721 PMC: 11218944. DOI: 10.1371/journal.pone.0306515.


Innovation in pathogenesis and management of aortic aneurysm.

Barkhordarian M, Tran H, Menon A, Pulipaka S, Kianifar Aguilar I, Fuertes A World J Exp Med. 2024; 14(2):91408.

PMID: 38948412 PMC: 11212750. DOI: 10.5493/wjem.v14.i2.91408.


The key role of miRNA in syndromic and sporadic forms of ascending aortic aneurysms as biomarkers and targets of novel therapeutic strategies.

Terriaca S, Monastero R, Orlandi A, Balistreri C Front Genet. 2024; 15:1365711.

PMID: 38450200 PMC: 10915088. DOI: 10.3389/fgene.2024.1365711.


References
1.
Gerdes L, Lindholt J, Vammen S, Henneberg E, Fasting H . Apolipoprotein E genotype is associated with differential expansion rates of small abdominal aortic aneurysms. Br J Surg. 2000; 87(6):760-5. DOI: 10.1046/j.1365-2168.2000.01486.x. View

2.
Elmore J, Obmann M, Kuivaniemi H, Tromp G, Gerhard G, Franklin D . Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association. J Vasc Surg. 2009; 49(6):1525-31. DOI: 10.1016/j.jvs.2009.01.041. View

3.
Collod-Beroud G, Le Bourdelles S, Ades L, Ala-Kokko L, Booms P, Boxer M . Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum Mutat. 2003; 22(3):199-208. DOI: 10.1002/humu.10249. View

4.
Milewicz D, Regalado E . Use of genetics for personalized management of heritable thoracic aortic disease: how do we get there?. J Thorac Cardiovasc Surg. 2014; 149(2 Suppl):S3-5. PMC: 4354949. DOI: 10.1016/j.jtcvs.2014.07.070. View

5.
Ogata T, Shibamura H, Tromp G, Sinha M, Goddard K, Sakalihasan N . Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg. 2005; 41(6):1036-42. PMC: 1249499. DOI: 10.1016/j.jvs.2005.02.020. View